Selective use of sentinel lymph node surgery during prophylactic mastectomy

Area of Science:

• Oncology
• Surgical Oncology
• Breast Cancer Research

Background:

• Prophylactic mastectomy (PM) patients with invasive cancer require axillary lymph node dissection for staging.
• Sentinel lymph node (SLN) surgery is often advocated during PM to identify nodal metastasis.
• The study evaluates the incidence of invasive cancer in PM and associated risk factors to inform SLN surgery decisions.

Purpose of the Study:

• To determine the invasive cancer rate in patients undergoing prophylactic mastectomy (PM).
• To identify clinical, radiographic, and pathologic factors associated with invasive cancer in PM specimens.
• To provide evidence-based guidance on the utility of sentinel lymph node (SLN) surgery in PM.

Main Methods:

• Retrospective analysis of a prospective database of patients undergoing PM.
• Data collection included clinical, radiographic, and pathologic information.
• Study period: January 2000 to July 2005 at M. D. Anderson Cancer Center.

Main Results:

• Of 436 PM cases, 5% had cancer, predominantly ductal carcinoma in situ (DCIS).
• Only 1.8% of cases revealed invasive cancer (mean tumor size 5 mm).
• Increased invasive cancer risk observed in postmenopausal women, those >60 years, and with a history of lobular carcinoma (LCIS or invasive lobular carcinoma).

Conclusions:

• The overall frequency of invasive cancer identified during prophylactic mastectomy is low.
• Routine sentinel lymph node (SLN) surgery for all prophylactic mastectomy (PM) patients is not generally warranted.
• Consider SLN surgery for higher-risk PM patients, including older women and those with a history of lobular neoplasia.